Rafferty Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
Rafferty Asset Management, LLC
- $28.9 Billion
- Q3 2024
A detailed history of Rafferty Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 138,042 shares of SRPT stock, worth $17.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
138,042
Previous 146,584
5.83%
Holding current value
$17.2 Million
Previous $23.2 Million
25.56%
% of portfolio
0.06%
Previous 0.09%
Shares
23 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.12 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$781 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$544 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$533 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...